Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2015 4
2016 2
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Shah BD, Bishop MR, Oluwole OO, Logan AC, Baer MR, Donnellan WB, O'Dwyer KM, Holmes H, Arellano ML, Ghobadi A, Pagel JM, Lin Y, Cassaday RD, Park JH, Abedi M, Castro JE, DeAngelo DJ, Malone AK, Mawad R, Schiller GJ, Rossi JM, Bot A, Shen T, Goyal L, Jain RK, Vezan R, Wierda WG. Shah BD, et al. Among authors: mawad r. Blood. 2021 Jul 8;138(1):11-22. doi: 10.1182/blood.2020009098. Blood. 2021. PMID: 33827116 Free PMC article. Clinical Trial.
Pembrolizumab immunotherapy for relapsed CNS Lymphoma.
Graber JJ, Plato B, Mawad R, Moore DJ. Graber JJ, et al. Among authors: mawad r. Leuk Lymphoma. 2020 Jul;61(7):1766-1768. doi: 10.1080/10428194.2020.1742903. Epub 2020 Mar 23. Leuk Lymphoma. 2020. PMID: 32204633 No abstract available.
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.
Ravandi F, Bashey A, Foran J, Stock W, Mawad R, Short N, Yilmaz M, Kantarjian H, Odenike O, Patel A, Garcha R, Ainsworth WB, Clynes R, Kanodia J, Ding Y, Li H, Kye S, Mims A. Ravandi F, et al. Among authors: mawad r. Blood Adv. 2023 Nov 14;7(21):6492-6505. doi: 10.1182/bloodadvances.2023010956. Blood Adv. 2023. PMID: 37647601 Free PMC article. Clinical Trial.
Myeloid sarcoma of the heart.
Mawad R, Wu D, Abkowitz JL, Walter RB. Mawad R, et al. Leuk Lymphoma. 2012 Dec;53(12):2511-4. doi: 10.3109/10428194.2012.685736. Epub 2012 May 21. Leuk Lymphoma. 2012. PMID: 22506643 Free PMC article. No abstract available.
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.
Orozco JJ, Kenoyer A, Balkin ER, Gooley TA, Hamlin DK, Wilbur DS, Hylarides MD, Frost SH, Mawad R, O'Donnell P, Sandmaier BM, Fuchs EJ, Luznik L, Green DJ, Gopal AK, Press OW, Pagel JM. Orozco JJ, et al. Among authors: mawad r. Blood. 2016 Jan 21;127(3):352-9. doi: 10.1182/blood-2014-12-617019. Epub 2015 Nov 17. Blood. 2016. PMID: 26576864 Free PMC article.
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, Ram R, Dabaja B, Rondon G, Champlin R, Sandmaier BM, Doney K, Bar M, Kebriaei P. Hamdi A, et al. Among authors: mawad r. Biol Blood Marrow Transplant. 2014 Nov;20(11):1767-71. doi: 10.1016/j.bbmt.2014.07.005. Epub 2014 Jul 10. Biol Blood Marrow Transplant. 2014. PMID: 25017763 Free PMC article.
15 results